In patients with impaired renal function, special care should be exercised when prescribing potassium salts because of the risk of hyperkalaemia. The serum electrolytes should be monitored in these patients and also in patients with congestive heart failure, especially if under treatment with digitalis, in whom hypokalaemia should be avoided.
During KSR administration, laboratory monitoring of serum electrolyte levels should be done periodically.